Adding to the evidence base: the lonely female partner: a central aspect of prostate cancer
Sublett, C.M.
Urologic Nursing 31(5): 300-301
2011
ISSN/ISBN: 1053-816X PMID: 22073901 Document Number: 650408
Document emailed within 1 workday
Related Documents
Sublett, C.M. 2016: Application to the Evidence Base: Decision-Making in Prostate Cancer: Active Surveillance over other Treatment Options Urologic Nursing 36(3): 150-152Sublett, C.M. 2014: Adding to the evidence base: the effect of collection method on urinalysis in women with pelvic organ prolapse Urologic Nursing 34(3): 131-132
Bourlon, M.ía.T.; Mora, M.; Hinojosa-Fano, J.; Martínez-Benitez, B.; Amini, A.; Castillejos-Molina, R.; Glodé, L.M. 2016: Man with Locally Advanced, High-Risk Prostate Cancer Asks about Adding Chemotherapy to his Treatment Oncology 30(1): 94-98
Miyamoto, S.; Jimbo, H.; Totsuka, Y.; Mashimo, T.; Umeyama, T.; Uehara, H.; Shinozaki, T. 1995: Change in serum prostate specific antigen values in men who had no evidence of prostate cancer on initial biopsy Hinyokika Kiyo. Acta Urologica Japonica 41(10): 767-770
Bourlon, M.T.; Glodé, L.M.; Crawford, E.D. 2014: Base of the skull metastases in metastatic castration-resistant prostate cancer Oncology 28(12): 1115-1116; 1124
Hanks, G.E.; Hanlon, A.L.; Horwitz, E.M. 2001: Evidence for cure of 'young' men with prostate cancer Oncology 15(5): 563-567; Discussion: 571-574
Ward-Smith, P. 2009: Screening and preventing prostate cancer: implementing the evidence Urologic Nursing 29(6): 437-9 443
Bhatnagar, V.; Kaplan, R.M. 2005: Treatment options for prostate cancer: evaluating the evidence American Family Physician 71(10): 1915-1922
Hoffman, K.S.; Hoffman, L.L. 1994: Effects of adding sacral base leveling to osteopathic manipulative treatment of back pain: a pilot study Journal of the American Osteopathic Association 94(3): 217
Wang, W.; Peng, R.-x.; Shi, G.-w.; Chen, S.-y.; Ding, Q.; He, J.-y. 2015: Treatment of castration-resistant prostate cancer: Evidence-based clinical practice Zhonghua Nan Ke Xue 21(12): 1121-1124
Griniatsos, J.; Diamantis, E.; Gioti, J.; Karyda, I.; Vassilopoulos, P.P.; Agnanti, N. 1998: Correlation of prostate specific antigen immunoactivity (IR-PSA) to other prognostic factors in female breast cancer Anticancer Research 18(1b): 683-688
Rahman, F.; Rahardjo, H.Erlianti.; Ariwicaksono, S.Cahyo.; Hafizar, H.; Sembiring, M.Gozali.Arif.; Andika, R.; Patandung, R.; Hidianingsih, S.; Hotasi, S.L. 2017: The Role of Docetaxel in Non-Castrate Resistant Metastatic Prostate Cancer: An Evidence-based Case Report Acta Medica Indonesiana 49(1): 74-78
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Murray, M.D.; Darvell, B.W. 1991: An aspect of denture base retention: direct measurement of force due to surface tension International Journal of Prosthodontics 4(4): 388-396
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Ragde, H.; Grado, G.L.; Nadir, B.S. 2001: Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Archivos Espanoles de Urologia 54(7): 739-747
Liu, J-he.; Li, H-wei.; Tong, M.; Li, M.; Na, Y-qun. 2004: Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer Zhonghua Yi Xue Za Zhi 84(5): 364-368